◆ NeutralPODD
PODD DEADLINE: Levi & Korsinsky Reminds Insulet Corporation Investors of Upcoming Securities Class Action Deadline
GlobeNewswire Inc.·
Insulet Corporation faces a securities class action lawsuit over defective cannula manufacturing in Omnipod insulin delivery devices. Approximately 7 million Pods were affected by manufacturing defects causing insulin under-delivery. The stock declined from $236 to $146.01 per share following two Medical Device Corrections. Investors who purchased securities between February 21, 2025 and May 26, 2026 may be eligible for compensation, with a lead plaintiff deadline of August 31, 2026.
Read Full Article at GlobeNewswire Inc. →